The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Disease Drugs Market Research Report 2024
Synopsis
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
The global Infectious Disease Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Drugs.
Report Scope
The Infectious Disease Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
The global Infectious Disease Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Drugs.
Report Scope
The Infectious Disease Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterials
1.2.3 Antiviral drugs
1.2.4 Antiparasitic drugs
1.2.5 Antifungal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Drugs Market Perspective (2019-2030)
2.2 Infectious Disease Drugs Growth Trends by Region
2.2.1 Global Infectious Disease Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Drugs Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Drugs Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Drugs Market Dynamics
2.3.1 Infectious Disease Drugs Industry Trends
2.3.2 Infectious Disease Drugs Market Drivers
2.3.3 Infectious Disease Drugs Market Challenges
2.3.4 Infectious Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Drugs Players by Revenue
3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
3.4 Global Infectious Disease Drugs Market Concentration Ratio
3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2023
3.5 Infectious Disease Drugs Key Players Head office and Area Served
3.6 Key Players Infectious Disease Drugs Product Solution and Service
3.7 Date of Enter into Infectious Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Drugs Breakdown Data by Type
4.1 Global Infectious Disease Drugs Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Drugs Breakdown Data by Application
5.1 Global Infectious Disease Drugs Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Drugs Market Size (2019-2030)
6.2 North America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Drugs Market Size by Country (2019-2024)
6.4 North America Infectious Disease Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Drugs Market Size (2019-2030)
7.2 Europe Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Drugs Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Drugs Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Drugs Market Size (2019-2030)
9.2 Latin America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Drugs Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Drugs Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Disease Drugs Introduction
11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Infectious Disease Drugs Introduction
11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2019-2024)
11.3.5 Merck & Co. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Infectious Disease Drugs Introduction
11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Infectious Disease Drugs Introduction
11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Infectious Disease Drugs Introduction
11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 Shire
11.7.1 Shire Company Detail
11.7.2 Shire Business Overview
11.7.3 Shire Infectious Disease Drugs Introduction
11.7.4 Shire Revenue in Infectious Disease Drugs Business (2019-2024)
11.7.5 Shire Recent Development
11.8 Grifols
11.8.1 Grifols Company Detail
11.8.2 Grifols Business Overview
11.8.3 Grifols Infectious Disease Drugs Introduction
11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2019-2024)
11.8.5 Grifols Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2019-2024)
11.9.5 Johnson & Johnson Recent Development
11.10 Protein Sciences
11.10.1 Protein Sciences Company Detail
11.10.2 Protein Sciences Business Overview
11.10.3 Protein Sciences Infectious Disease Drugs Introduction
11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.10.5 Protein Sciences Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Infectious Disease Drugs Introduction
11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2019-2024)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
